Merck公司高管在2026年2月6日出售了价值6.4百万美元的股票,作为丰厚的收入和提升的引导提升了股票。 Merck executives sold shares worth $6.4M on Feb. 6, 2026, as strong earnings and raised guidance boosted stock.

根据证交会的文件,Merck & Co. 执行官Richard Deluca和Johannes Jacobus Oosthuizen于2026年2月6日共出售52 685股股票,筹集了约640万美元。 On February 6, 2026, Merck & Co. executives Richard Deluca and Johannes Jacobus Oosthuizen sold a combined 52,685 shares, raising about $6.4 million, according to SEC filings. 该公司报告Q4收入丰厚,经调整的EPS收入为2.04美元,收入为164亿美元,超过了预期,使股票涨到121.92美元。 The company reported strong Q4 earnings, with adjusted EPS of $2.04 and revenue of $16.4 billion, surpassing expectations and driving a stock rise to $121.92. Merck将其2026年全年EPS指导提高到5.00至5.15美元,宣布季度红利为0.85美元,并保持了“长期”分析师共识评级。 Merck raised its 2026 full-year EPS guidance to $5.00–$5.15, declared a quarterly dividend of $0.85, and maintained a "Hold" analyst consensus rating.